MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 160 filers reported holding MIRUM PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,675,943 | +599.3% | 432,783 | +472.5% | 0.01% | +400.0% |
| Q2 2023 | $1,955,772 | +113475.6% | 75,600 | +5.4% | 0.00% | 0.0% |
| Q1 2023 | $1,722 | +20.6% | 71,694 | -2.1% | 0.00% | 0.0% |
| Q4 2022 | $1,428 | -99.9% | 73,248 | -12.5% | 0.00% | 0.0% |
| Q3 2022 | $1,760,000 | +132.8% | 83,745 | +115.8% | 0.00% | – |
| Q2 2022 | $756,000 | -54.8% | 38,803 | -48.6% | 0.00% | -100.0% |
| Q1 2022 | $1,672,000 | +1014.7% | 75,555 | +585.6% | 0.00% | – |
| Q4 2021 | $150,000 | -24.6% | 11,020 | 0.0% | 0.00% | – |
| Q3 2021 | $199,000 | +4.2% | 11,020 | 0.0% | 0.00% | – |
| Q2 2021 | $191,000 | -32.7% | 11,020 | -23.0% | 0.00% | – |
| Q1 2021 | $284,000 | -34.4% | 14,320 | -42.3% | 0.00% | – |
| Q4 2020 | $433,000 | -10.0% | 24,811 | -0.5% | 0.00% | – |
| Q3 2020 | $481,000 | +138.1% | 24,946 | +140.0% | 0.00% | – |
| Q2 2020 | $202,000 | – | 10,396 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 6,470,392 | $204,464,387 | 13.58% |
| NEA Management Company, LLC | 2,186,243 | $69,085,279 | 5.34% |
| TANG CAPITAL MANAGEMENT LLC | 1,137,107 | $35,932,581 | 5.07% |
| BOONE CAPITAL MANAGEMENT LLC | 389,791 | $12,317,396 | 3.89% |
| Highlander Partners, L.P. | 122,980 | $3,886,168 | 3.84% |
| BVF INC/IL | 4,370,024 | $138,092,758 | 3.72% |
| Prosight Management, LP | 353,508 | $11,170,853 | 3.54% |
| Novo Holdings A/S | 1,500,000 | $47,400,000 | 3.50% |
| Nicholas Investment Partners, LP | 1,199,366 | $37,899,966 | 2.83% |
| Eventide Asset Management | 3,958,579 | $125,091,097 | 2.25% |